Andean Precious Metals (CVE:APM) Shares Down 5.1% – Time to Sell?

Andean Precious Metals Corp. (CVE:APM) dropped 5.1% during mid-day trading on Friday . The company traded as low as C$1.26 and last traded at C$1.29. Approximately 88,871 shares traded hands during trading, a decline of 54% from the average daily volume of 192,505 shares. The stock had previously closed at C$1.36.

Wall Street Analysts Forecast Growth

Separately, Desjardins raised Andean Precious Metals to a “moderate buy” rating in a research report on Thursday, October 31st.

Andean Precious Metals Stock Performance

The firm has a market capitalization of C$192.67 million, a PE ratio of 3.39 and a beta of 1.22. The business’s 50 day moving average price is C$1.46 and its 200-day moving average price is C$1.25.

Insider Buying and Selling at Andean Precious Metals

In other news, insider 2176423 Ontario Ltd. bought 213,800 shares of the company’s stock in a transaction on Wednesday, October 2nd. The stock was bought at an average cost of C$1.38 per share, with a total value of C$294,530.88. Insiders have bought a total of 306,200 shares of company stock valued at $432,953 over the last quarter. 69.37% of the stock is owned by company insiders.

About Andean Precious Metals

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.